Mhairi Copland

32PUBLICATIONS
98CO-AUTHORS
Haematological tumoursGene and molecular therapyMolecular targetsPsychosocial aspects of childbirth and perinatal mental healthCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jan 07, 2026
Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrow.

S D Patterson, A Gottschalk, C Hayden

|May 21, 2025
Venetoclax-based non-intensive combinations for relapsed/refractory acute myeloid leukaemia-Real-world data from a UK-wide programme.

Henry Wood, Jenny O'Nions, Wei Yee Chan

|Sep 19, 2024
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy.

Andrew J Innes, Chloe Hayden, Victoria Orovboni

|Jun 12, 2024
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia.

Ahmed Khalaf, Lucie de Beauchamp, Eric Kalkman

|May 03, 2024
Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy.

H F Robertson, D Milojkovic, N Butt

|Mar 29, 2024
Targeting BCR-ABL1-positive leukaemias: a review article.

Steven Leak, Gillian A Horne, Mhairi Copland

Pageof 6

Frequent Collaborators

8 joint publications

Karen Dunn

7 joint publications

G Vignir Helgason

5 joint publications

Mary T Scott

4 joint publications

Gillian Horne